Blocking induction of T helper type 2 responses prevents development of disease in a model of childhood asthma

Clinical and Experimental Immunology

Volumn 165, Issue 1, 2011, Pages 19-28

  Siegle, J S ^a   Hansbro, N ^b   Dong, C ^c   Angkasekwinai, P ^d   Foster, P S ^b   Kumar, R K ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c UNIVERSITY OF TEXAS   (United States)

^d THAMMASAT UNIVERSITY   (Thailand)

Author keywords

Airway inflammation; Airway remodelling; Allergy; Th17 response; Th2 response

Indexed keywords

BETA GALACTOSIDASE MONOCLONAL ANTIBODY; INTERLEUKIN 25 ANTIBODY; INTERLEUKIN 4 ANTIBODY; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; OVALBUMIN; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

AEROSOL; AIRWAY REMODELING; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL HYPERPLASIA; CHILDHOOD DISEASE; CHRONIC DISEASE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DISEASE EXACERBATION; EOSINOPHIL; EPITHELIUM CELL; GOBLET CELL; IMMUNE RESPONSE; IMMUNOTHERAPY; INFLAMMATORY CELL; LYMPHOCYTE; MACROPHAGE; METAPLASIA; MOUSE; MURINE PNEUMONIA VIRUS; NEUTROPHIL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; TH17 CELL; TH2 CELL;

AIRWAY REMODELING; ALLERGENS; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, BLOCKING; ASTHMA; CELLS, CULTURED; CHILD; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GOBLET CELLS; HUMANS; HYPERPLASIA; INTERLEUKIN-4; INTERLEUKINS; MICE; MICE, INBRED BALB C; MURINE PNEUMONIA VIRUS; OVALBUMIN; PNEUMONIA; PNEUMOVIRUS INFECTIONS; TH2 CELLS;

EID: 79958083858     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04392.x     Document Type: Article

References (34)

1. Holt PG, Sly PD. Prevention of allergic respiratory disease in infants: current aspects and future perspectives. Curr Opin Allergy Clin Immunol 2007; 7:547-55.
2. Kristjansson S, Bjarnarson SP, Wennergren G etal. Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response. J Allergy Clin Immunol 2005; 116:805-11.
3. Kusel MM, de Klerk NH, Kebadze T etal. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 2007; 119:1105-10.
4. Jackson DJ, Gangnon RE, Evans MD etal. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 2008; 178:667-72.
5. Siegle JS, Hansbro N, Herbert C etal. Early-life viral infection and allergen exposure interact to induce an asthmatic phenotype in mice. Respir Res 2010; 11:14.
6. Domachowske JB, Bonville CA, Rosenberg HF. Animal models for studying respiratory syncytial virus infection and its long term effects on lung function. Pediatr Infect Dis J 2004; 23:S228-34.
7. Rosenberg HF, Domachowske JB. Pneumonia virus of mice: severe respiratory infection in a natural host. Immunol Lett 2008; 118:6-12.
8. Paul WE, Zhu J. How are T(H)2-type immune responses initiated and amplified? Nat Rev Immunol 2010; 10:225-35.
9. Angkasekwinai P, Park H, Wang YH etal. Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med 2007; 204:1509-17.
10. Temelkovski J, Hogan SP, Shepherd DP, Foster PS, Kumar RK. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 1998; 53:849-56.
11. Siegle JS, Hansbro N, Herbert C, Yang M, Foster PS, Kumar RK. Airway hyperreactivity in exacerbation of chronic asthma is independent of eosinophilic inflammation. Am J Respir Cell Mol Biol 2006; 35:565-70.
12. Ohara J, Paul WE. Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature 1985; 315:333-6.
13. Schneider T, Issekutz AC. Quantitation of eosinophil and neutrophil infiltration into rat lung by specific assays for eosinophil peroxidase and myeloperoxidase. Application in a Brown Norway rat model of allergic pulmonary inflammation. J Immunol Methods 1996; 198:1-14.
14. Foster PS, Webb DC, Yang M, Herbert C, Kumar RK. Dissociation of T helper type 2 cytokine-dependent airway lesions from signal transducer and activator of transcription 6 signalling in experimental chronic asthma. Clin Exp Allergy 2003; 33:688-95.
15. Herbert C, Hettiaratchi A, Webb DC, Thomas PS, Foster PS, Kumar RK. Suppression of cytokine expression by roflumilast and dexamethasone in a mouse model of chronic asthma. Clin Exp Allergy 2008; 38:847-56.
16. Kumar RK, Herbert C, Foster PS. Expression of growth factors by airway epithelial cells in a model of chronic asthma: regulation and relationship to subepithelial fibrosis. Clin Exp Allergy 2004; 34:567-75.
17. Herbert C, Scott MM, Scruton KH etal. Alveolar macrophages stimulate enhanced cytokine production by pulmonary CD4+ T-lymphocytes in an exacerbation of murine chronic asthma. Am J Pathol 2010; 177:1657-64.
18. Yi X, Feng F, Xiang Z, Ge L. The effects of allitridin on the expression of transcription factors T-bet and GATA-3 in mice infected by murine cytomegalovirus. J Med Food 2005; 8:332-6.
19. Norzila MZ, Fakes K, Henry RL, Simpson J, Gibson PG. Interleukin-8 secretion and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma. Am J Respir Crit Care Med 2000; 161:769-74.
20. Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 2008; 372:1107-19.
21. Barrett NA, Austen KF. Innate cells and T helper 2 cell immunity in airway inflammation. Immunity 2009; 31:425-37.
22. Wang YH, Liu YJ. Thymic stromal lymphopoietin, OX40-ligand, and interleukin-25 in allergic responses. Clin Exp Allergy 2009; 39:798-806.
23. Kaiko GE, Phipps S, Angkasekwinai P, Dong C, Foster PS. NK cell deficiency predisposes to viral-induced Th2-type allergic inflammation via epithelial-derived IL-25. J Immunol 2010; 185:4681-90.
24. Alcorn JF, Crowe CR, Kolls JK. TH17 cells in asthma and COPD. Annu Rev Physiol 2010; 72:495-516.
25. Furuzawa-Carballeda J, Vargas-Rojas MI, Cabral AR. Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 2007; 6:169-75.
26. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol 2009; 27:485-517.
27. Zaph C, Du Y, Saenz SA etal. Commensal-dependent expression of IL-25 regulates the IL-23-IL-17 axis in the intestine. J Exp Med 2008; 205:2191-8.
28. Kleinschek MA, Owyang AM, Joyce-Shaikh B etal. IL-25 regulates Th17 function in autoimmune inflammation. J Exp Med 2007; 204:161-70.
29. Laan M, Palmberg L, Larsson K, Linden A. Free, soluble interleukin-17 protein during severe inflammation in human airways. Eur Respir J 2002; 19:534-7.
30. Bullens DM, Truyen E, Coteur L etal. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir Res 2006; 7:135.
31. McKinley L, Alcorn JF, Peterson A etal. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol 2008; 181:4089-97.
32. Schmitz J, Owyang A, Oldham E etal. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23:479-90.
33. Al-Shami A, Spolski R, Kelly J, Keane-Myers A, Leonard WJ. A role for TSLP in the development of inflammation in an asthma model. J Exp Med 2005; 202:829-39.
34. Lambrecht BN, Hammad H. Biology of lung dendritic cells at the origin of asthma. Immunity 2009; 31:412-24.